These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34012481)

  • 1. Prognostic utility of inflammation-based biomarkers, neutrophil-lymphocyte ratio and change in neutrophil-lymphocyte ratio, in surgically resected lung cancers.
    Thompson D; Perry LA; Renouf J; Vodanovich D; Hong Lee AH; Dimiri J; Wright G
    Ann Thorac Med; 2021; 16(2):148-155. PubMed ID: 34012481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer.
    Jin F; Han A; Shi F; Kong L; Yu J
    Onco Targets Ther; 2016; 9():6529-6537. PubMed ID: 27799800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The post-treatment neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after treatment of stage III non-small-cell lung cancer with conventionally fractionated radiotherapy.
    Wang D; Guo D; Li A; Wang P; Teng F; Yu J
    Future Oncol; 2020 Mar; 16(9):439-449. PubMed ID: 32141321
    [No Abstract]   [Full Text] [Related]  

  • 4. Perioperative change in neutrophil-to-lymphocyte ratio (NLR) is a prognostic factor in patients with completely resected primary pulmonary sarcomatoid carcinoma.
    Seong YW; Han SJ; Jung W; Jeon JH; Cho S; Jheon S; Kim K
    J Thorac Dis; 2019 Mar; 11(3):819-826. PubMed ID: 31019770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 inhibitors.
    Chen S; Li R; Zhang Z; Huang Z; Cui P; Jia W; Zhang S; Tao H; Wang L; Li X; Wang J; Ma J; Liu Z; Huang D; Zheng X; Saito Y; Ichiki Y; Hu Y
    Transl Lung Cancer Res; 2021 Mar; 10(3):1397-1407. PubMed ID: 33889518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing neutrophil-to-lymphocyte ratio following radiation is a poor prognostic factor and directly correlates with splenic radiation dose in pancreatic cancer.
    Wolfe AR; Siedow M; Nalin A; DiCostanzo D; Miller ED; Diaz DA; Arnett A; Cloyd JM; Dillhoff M; Ejaz A; Tsung A; Williams TM
    Radiother Oncol; 2021 May; 158():207-214. PubMed ID: 33667588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Elevations of Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios Predict Postoperative Pulmonary Complications in Non-small Cell Lung Cancer Patients: A Retrospective Cohort Study.
    Wang Y; Hu X; Su MC; Wang YW; Che GW
    Curr Med Sci; 2020 Apr; 40(2):339-347. PubMed ID: 32337695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade.
    Shang J; Han X; Zha H; Tao H; Li X; Yuan F; Chen G; Wang L; Ma J; Hu Y
    Front Oncol; 2021; 11():585271. PubMed ID: 33718140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.
    Chen L; Zeng H; Yang J; Lu Y; Zhang D; Wang J; Kuang C; Zhu S; Wang M; Ma X
    BMC Cancer; 2018 Aug; 18(1):816. PubMed ID: 30103707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative to postoperative change in neutrophil-to-lymphocyte ratio predict survival in colorectal cancer patients.
    Guo D; Han A; Jing W; Chen D; Jin F; Li M; Kong L; Yu J
    Future Oncol; 2018 May; 14(12):1187-1196. PubMed ID: 29302993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A persistent high neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with colorectal cancer undergoing resection.
    Cui M; Xu R; Yan B
    Mol Clin Oncol; 2020 Nov; 13(5):63. PubMed ID: 32963782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline neutrophil-to- ratio combined with the change during treatment provides risk stratification for metastatic malignant melanoma patients treated with PD-1 inhibitors in a Chinese population.
    Wang C; Liu S; Li X; Cui K; Zhang W; Du Y
    Front Oncol; 2023; 13():1118301. PubMed ID: 37152022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.
    Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y
    Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung Cancer.
    Guo D; Jin F; Jing W; Li M; Chen D; Zou B; Jiang G; Fu L; Zhu H; Kong L; Wu J; Yu J; Yue J
    Clin Lung Cancer; 2019 Nov; 20(6):412-419. PubMed ID: 31300364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.
    Wang X; Cao L; Li S; Wang F; Huang D; Jiang R
    J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic significance of the combination of preoperative fibrinogen and the neutrophil-lymphocyte ratio in patients with non-small cell lung cancer following surgical resection.
    Liang HG; Gao K; Jia R; Li J; Wang C
    Oncol Lett; 2019 Feb; 17(2):1435-1444. PubMed ID: 30675197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.